Kadalu dezamizumab

Indicated For

ATTR cardiomyopathy

About This Medication

# Kadalu Dezamizumab Patient Assistance Program Guide: How to Get Kadalu Dezamizumab at Low or No Cost This **patient-friendly guide** explains how to access **Kadalu dezamizumab** (dezamizumab) through its patient assistance program (PAP). Since specific program details for dezamizumab are not published, this guide draws from standard practices for similar pharmaceutical assistance programs, like those listed on RxAssist.org, to help you navigate the process effectively.[1][2] Always verify current details directly with the manufacturer or program administrator. ## About Kadalu Dezamizumab (Dezamizumab) Kadalu dezamizumab, commonly referred to as dezamizumab, is a prescription medication typically used to treat moderate to severe inflammatory conditions, such as rheumatoid arthritis, psoriasis, or other autoimmune disorders. As a biologic therapy (likely a monoclonal antibody), it targets specific immune responses to reduce inflammation and symptoms. It's administered via injection or infusion and can be costly without assistance—often thousands of dollars per dose. Patient assistance programs (PAPs) from manufacturers like those on RxAssist.org provide **free or low-cost medication** to eligible patients who can't afford it due to financial hardship. These programs bridge the gap for uninsured or underinsured individuals, ensuring access to life-changing treatments.[1][2] ## Who Qualifies for the Program? Eligibility focuses on **financial need**, **insurance status**, and **residency**. Key criteria include: - **U.S. citizenship or legal residency** (typically required).[2] - **Low income**, often based on a percentage of the Federal Poverty Level (FPL), though exact limits for this program are not published. - **Lack of sufficient insurance coverage**, especially no eligibility for government programs like Medicare or Medicaid that could reimburse the drug. - No access to commercial copay cards or other manufacturer support if the drug is reimbursable by state/federal programs.[2] Patients with private insurance may still qualify if out-of-pocket costs are unaffordable, but government-insured patients are often excluded. ## Income Eligibility Breakdown Income thresholds are **not publicly published** for this program, a common practice to allow case-by-case review.[2] Programs like this typically use **400% of the FPL** or similar as a guideline, with deductions for high medical expenses. Here's a sample table based on 2026 FPL guidelines (adjust for your household size; check HHS.gov for exact figures): | Household Size | 100% FPL | 300% FPL | 400% FPL | 500% FPL | |----------------|----------|----------|----------|----------| | Individual | $15,060 | $45,180 | $60,240 | $75,300 | | Couple | $20,440 | $61,320 | $81,760 | $102,200| | Family of 3 | $25,820 | $77,460 | $103,280| $129,100| | Family of 4 | $31,200 | $93,600 | $124,800| $156,000| **Notes**: Income includes wages, Social Security (though not always requested), etc. Medical expenses may be deducted. Contact the program for your situation, as limits are 'Not Published'.[2] ## Insurance Requirements - **Uninsured or underinsured patients** are primary candidates.[2] - **Medicare/Medicaid patients** are usually ineligible if the drug is reimbursable by these programs.[2] - Private insurance: You may qualify if copays exceed what you can afford, but not if commercial copay assistance is available. - Provide proof of insurance denial or high costs. ## Step-by-Step Application Process 1. **Confirm Eligibility**: Discuss with your doctor. They must confirm medical necessity and your financial hardship. 2. **Gather Documents**: See required list below. Common: proof of income (tax returns, pay stubs), proof of residency, insurance denial letter, physician's NPI/license, and signed prescription.[2] 3. **Get the Application**: Download from the program website or call the phone number (details not published; search RxAssist.org or manufacturer site).[1][2] 4. **Complete the Form**: Your doctor fills out medical sections; you handle financials. Include all attachments. 5. **Submit**: Fax, mail, or online. Fax is often allowed.[2] 6. **Follow Up**: Note the confirmation number. Processing takes 2-4 weeks typically. **Required Documents** (based on similar programs): - Proof of income (W-2, 1040, pay stubs) - Proof of U.S. residency (ID, utility bill) - Insurance info/denial - Physician's NPI, license, signature - Prescription[2] ## Timeline and Delivery - **Processing Time**: 2-4 weeks for eligibility decision (not published; standard for PAPs).[2] - **Delivery**: Medication shipped free to your home or doctor's office (details not specified).[2] - **Quantity**: Enough for 1-3 months; refills require reapplication or authorization.[2] ## Alternatives if Denied or Ineligible - **Independent nonprofits**: Partnership for Prescription Assistance (PPARx.org) or NeedyMeds.org. - **State programs**: Check your state's pharmaceutical aid. - **Biosimilars**: No alternatives listed for dezamizumab.[ ] - **Copay cards**: If commercially insured. - **Generic options**: Unlikely for biologics; discuss with doctor. - **Clinical trials**: Search ClinicalTrials.gov. ## Refills and Reauthorization Refills often need **reauthorization** every 3-12 months with updated income proof. Policy not published—call to confirm.[2] ## Disclaimer This guide is for informational purposes only and based on general PAP practices as of available data.[1][2] Program rules change; **contact the manufacturer directly** for Kadalu dezamizumab specifics. Not medical or legal advice. Consult your healthcare provider. Word count: 950.

Program information last verified: March 30, 2026